- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Uncovering the role of IFNAR1 in experimental cerebral malaria ; volume:9 ; number:2 ; day:20 ; month:10 ; year:2010 ; pages:1 ; date:12.2010
Malaria journal ; 9, Heft 2 (20.10.2010), 1, 12.2010
- Creator
-
Ball, Elizabeth
- Contributor
-
Gonçalves, Carlos Penha
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-9-S2-P3
- URN
-
urn:nbn:de:1111-2016080626033
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
05.06.0005, 12:04 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ball, Elizabeth
- Gonçalves, Carlos Penha
- SpringerLink (Online service)
Other Objects (12)
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Brain microvessel cross‐presentation is a hallmark of experimental cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
Plasmodium berghei macrophage migration inhibitory factor (PbMIF) in experimental cerebral malaria
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Brain microvessel cross‐presentation is a hallmark of experimental cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase
Plasmodium berghei macrophage migration inhibitory factor (PbMIF) in experimental cerebral malaria
Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria
Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria
Experimental Cerebral Malaria Spreads along the Rostral Migratory Stream
Efficacy of intranasal administration of artesunate in experimental cerebral malaria
Brain microvessel cross‐presentation is a hallmark of experimental cerebral malaria
Controlled release of artemisone for the treatment of experimental cerebral malaria
Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase